Union Korea Pharm: Rights offering (paid-in capital increase) decision

This is a major-event report in which Union Korea Pharm says its board has decided to raise money by issuing new shares for cash (a paid-in capital increase). It usually tells shareholders that the share count may rise, which can dilute existing holdings unless they take part, and the filing normally sets out the size, price, purpose and schedule, which were not provided here. Union Korea Pharm filed this on Oct 21, 2026.

Company filing